IBB vs NUGT
iShares Biotechnology ETF vs Direxion Daily Gold Miners Bull 2X ETF
- • IBB has the lower expense ratio at 0.44% vs 1.13% for NUGT.
- • NUGT pays a higher dividend yield (0.33%).
Side-by-side metrics
| Metric | IBB | NUGT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 1.13% |
Dividend yield Trailing 12-month yield. | 0.23% | 0.33% |
AUM Assets under management — bigger funds are typically more liquid. | $7.95B | $1.01B |
YTD return | 3.10% | 1.08% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.74 | 0.40 |
P/E ratio | 23.72 | 18.49 |
Last price | $170.10 | $183.09 |
Inception | — | — |
Issuer | iShares | Direxion |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
NUGT top holdings
| GDX | VanEck Gold Miners ETF | 51.49% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About NUGT
NUGT (Direxion Daily Gold Miners Bull 2X ETF) is 2x daily performance of gold mining stocks. Managed by Direxion, the fund carries $1.0B in assets under management, an expense ratio of 1.13%, a dividend yield of 0.33%. Its largest holding is VanEck Gold Miners ETF (GDX), which represents 51.5% of the portfolio. Basic Materials is the fund's largest sector exposure at 100.0%.